---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-248079"
form_type: "8-K"
ticker: "VERA"
cik: "0001831828"
company_name: "Vera Therapeutics, Inc."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:38:21.586409+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Vera Therapeutics launches $300M public offering of 7.1M shares at $42.00

## Summary
- 7,142,858 shares offered at $42.00/share; gross proceeds ~$300M before discounts and expenses.
- Underwriters have 30-day option to purchase up to 1,071,428 additional shares at the same price.
- Closing expected October 31, 2024; J.P. Morgan, Goldman Sachs, Evercore, Cantor Fitzgerald are underwriters.
- Offering made under automatic shelf registration statement on Form S-3; customary closing conditions apply.

## SEC filing metadata
- accession: 0001193125-24-248079
- form_type: 8-K
- ticker: VERA
- cik: 0001831828
- company_name: Vera Therapeutics, Inc.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831828/000119312524248079/0001193125-24-248079-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831828/000119312524248079/d787969d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-248079
- JSON: https://secwatch.observer/filing/0001193125-24-248079.json
- Plain text: https://secwatch.observer/filing/0001193125-24-248079.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.